An association between serum basic fibroblast growth factor (bFGF) and Bcl-2 in patients with chronic lymphocytic leukemia.

被引：0
|
作者：
Bairey, O
Zimra, Y
Rabizadeh, E
Shaklai, M
机构：
[1] Rabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
[2] Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4536
引用
收藏
页码：294B / 294B
页数：1
相关论文
共 50 条
  • [41] Antisense-mediated reduction in BCL-2 expression is associated with increased in vitro apoptosis in B-cell chronic lymphocytic leukemia.
    Pepper, C
    Thomas, A
    Hoy, T
    Bentley, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 84 - 84
  • [42] Bcl-2 expression levels in chronic lymphocytic leukemia: Correlation with other prognostic indicators
    Sargent, RL
    Craig, FE
    Swerdlow, SH
    MODERN PATHOLOGY, 2006, 19 : 245A - 245A
  • [43] Bcl-2 expression levels in chronic lymphocytic leukemia: Correlation with other prognostic indicators
    Sargent, RL
    Craig, FE
    Swerdlow, SH
    LABORATORY INVESTIGATION, 2006, 86 : 245A - 245A
  • [44] Poptosis dysregulation in B chronic lymphocytic leukemia: The Bcl-2 regulatory pathway is functional
    Paniagua, M
    Gartenhaus, R
    Tallman, M
    Goolsby, C
    CYTOMETRY, 2001, 46 (05): : 322 - 322
  • [45] The rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy target
    Brown, Jennifer R.
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2755 - 2756
  • [46] Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells
    Cervantes-Gomez, Fabiola
    Lavergne, Bethany
    Keating, Michael J.
    Wierda, William G.
    Gandhi, Varsha
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 436 - 444
  • [47] VEGF-induced survival of chronic lymphocytic leukemia is independent of Bcl-2 phosphorylation
    Wang, L
    Coad, JE
    Fortney, JM
    Gibson, LF
    LEUKEMIA, 2005, 19 (08) : 1486 - 1487
  • [48] The potential combination of BCL-2 inhibitors and ibrutinib as frontline therapy in chronic lymphocytic leukemia
    Aw, Andrew
    Brown, Jennifer R.
    LEUKEMIA & LYMPHOMA, 2017, 58 (10) : 2287 - 2297
  • [49] BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia
    Chong, Stephen Jun Fei
    Lu, Junyan
    Valentin, Rebecca
    Lehmberg, Timothy Z.
    Eu, Jie Qing
    Wang, Jing
    Zhu, Fen
    Kong, Li Ren
    Fernandes, Stacey M.
    Zhang, Jeremy
    Herbaux, Charles
    Goh, Boon Cher
    Brown, Jennifer R.
    Niemann, Carsten U.
    Huber, Wolfgang
    Zenz, Thorsten
    Davids, Matthew S.
    MOLECULAR CANCER, 2025, 24 (01)
  • [50] VEGF-induced survival of chronic lymphocytic leukemia is independent of Bcl-2 phosphorylation
    L Wang
    J E Coad
    J M Fortney
    L F Gibson
    Leukemia, 2005, 19 : 1486 - 1487
12345